Fairvalue-Calculator Fairvalue-Calculator
EN DE

Spago Nanomedical AB (SPAGO) Fair Value & Analysis

Healthcare · SE · Market cap 71.0M SEK

Pricekr 0.1130
Fair Valuekr 0.0500
Upside-55.8%
Quality95/100
Evidence: Low Range kr 0.0300 – kr 0.0600

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Spago Nanomedical AB (SPAGO) currently trades at kr 0.1130, while our model-based Fair Value estimate is kr 0.0500 — implying the stock looks roughly 55.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. The company was incorporated in 1999 and is based in Lund, Sweden.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Spago Nanomedical AB (SPAGO) undervalued?
As of Jun 26, 2026, our model estimates a fair value of kr 0.0500 versus a price of kr 0.1130 — about −56% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SPAGO?
Our 21-model fair value for Spago Nanomedical AB is kr 0.0500 (as of Jun 26, 2026), built from audited fundamentals. The current price is kr 0.1130.
What is the quality score of SPAGO?
Spago Nanomedical AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.